Alok K Gupta

Summary

Affiliation: Pennington Biomedical Research Center
Country: USA

Publications

  1. ncbi Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Hypertens Res 33:905-10. 2010
  2. ncbi Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    Diabetes Care 34:658-60. 2011
  3. ncbi Coexisting prehypertension and prediabetes in healthy adults: a pathway for accelerated cardiovascular events
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Hypertens Res 34:456-61. 2011
  4. ncbi Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    Cardiovasc Diabetol 9:58. 2010
  5. ncbi Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Diabetes Obes Metab 11:330-7. 2009
  6. ncbi Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    J Diabetes Complications 24:289-96. 2010
  7. ncbi Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    J Inflamm (Lond) 7:36. 2010
  8. ncbi Dysglycemia induces abnormal circadian blood pressure variability
    Sivarajan Kumarasamy
    Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA
    Cardiovasc Diabetol 10:104. 2011
  9. ncbi Incremental weight loss improves cardiometabolic risk in extremely obese adults
    William D Johnson
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Am J Med 124:931-8. 2011
  10. ncbi Effect of pioglitazone on energy intake and ghrelin in diabetic patients
    Corby K Martin
    Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
    Diabetes Care 33:742-4. 2010

Collaborators

Detail Information

Publications16

  1. ncbi Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Hypertens Res 33:905-10. 2010
    ..Clinical care designed to prevent progression from PreHTN to HTN (JNC 7 recommendation) may attenuate risk...
  2. ncbi Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    Diabetes Care 34:658-60. 2011
    ..To determine whether modest elevations of fasting serum glucose (FSG) and resting blood pressure (BP) in healthy adults are associated with differential serum vitamin D concentrations...
  3. ncbi Coexisting prehypertension and prediabetes in healthy adults: a pathway for accelerated cardiovascular events
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Hypertens Res 34:456-61. 2011
    ..High prevalence of Co-PreHTN+PreDM in healthy US adults, a strong correlate for dysregulated cardiometabolic risk factors, highlights a plausible accelerated pathway for early cardiovascular events...
  4. ncbi Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    Cardiovasc Diabetol 9:58. 2010
    ..Cardiovascular disease (CVD) risk, although perceived to be high, is often difficult to demonstrate in disease free (healthy) obese adults...
  5. ncbi Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Diabetes Obes Metab 11:330-7. 2009
    ..Treatment with thiazolidinediones (TZDs) produces weight gain...
  6. ncbi Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    J Diabetes Complications 24:289-96. 2010
    ..Pioglitazone (Pio) treatment induces weight gain in Type 2 diabetes mellitus (T2DM), which could worsen hepatic lipid accumulation, and alter adiponectin and high-sensitivity C-reactive protein (hs-CRP)...
  7. ncbi Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu
    Alok K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    J Inflamm (Lond) 7:36. 2010
    ..This cascade of events in some measure explains the susceptibility of obese adults for co-morbid conditions like diabetes mellitus and hypertension...
  8. ncbi Dysglycemia induces abnormal circadian blood pressure variability
    Sivarajan Kumarasamy
    Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA
    Cardiovasc Diabetol 10:104. 2011
    ..Prediabetes (PreDM) in asymptomatic adults is associated with abnormal circadian blood pressure variability (abnormal CBPV)...
  9. ncbi Incremental weight loss improves cardiometabolic risk in extremely obese adults
    William D Johnson
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Am J Med 124:931-8. 2011
    ....
  10. ncbi Effect of pioglitazone on energy intake and ghrelin in diabetic patients
    Corby K Martin
    Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
    Diabetes Care 33:742-4. 2010
    ..To measure ghrelin and energy intake in the laboratory after pioglitazone treatment...
  11. ncbi Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study
    Donna H Ryan
    Pennington Biomedical Research Center of Louisiana State University System, Baton Rouge, LA 70808, USA
    Arch Intern Med 170:146-54. 2010
    ....
  12. ncbi An assay to measure angiogenesis in human fat tissue
    Frank L Greenway
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Obes Surg 17:510-5. 2007
    ..Inhibition of angiogenesis reverses rodent obesity. A validated assay in human fat tissue is needed to study the role of angiogenesis in human obesity...
  13. ncbi Prediabetes is associated with abnormal circadian blood pressure variability
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808, USA
    J Hum Hypertens 22:627-33. 2008
    ..001). ACV detected with 7-day ABPM may account for the enhanced CVD risk in prediabetes. These findings provide a basis for larger-scale studies to assess the predictive value of 7-day ABPM over the long term...
  14. ncbi Template to improve glycemic control without reducing adiposity or dietary fat
    R Krishnapuram
    Infections and Obesity Laboratory, Pennington Biomedical Research Center, Louisiana State Univ System, 6400 Perkins Rd, Baton Rouge, LA 70808, USA
    Am J Physiol Endocrinol Metab 300:E779-89. 2011
    ..This metabolic engineering by Ad36 appears relevant to humans for developing more practical and effective antidiabetic approaches...
  15. ncbi Using intranasal lidocaine to reduce food intake
    F L Greenway
    Outpatient Clinic Unit, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Int J Obes (Lond) 31:858-63. 2007
    ..Develop a dose-response curve for the effect of intranasal lidocaine on food intake...
  16. ncbi Rational design of a combination medication for the treatment of obesity
    Frank L Greenway
    1Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA
    Obesity (Silver Spring) 17:30-9. 2009
    ..This novel treatment approach (BUP+NAL) holds promise for the treatment of obesity.\..